Global Life Science Instruments and Reagents Market: Forecast up to 2025

PrintEmail
April 2019 - 125 Pages - From $2,750 (15% discount available)
Description

The report cover may be different from the image shown.

The product will be delivered by email. If you have any question, want to preview some sample pages, or ask for custom research, please contact us. You can also check with us for possible discount. It is possible now to buy a part of the report in terms of chapter, section, data table or figure.

License Type

.gif" type="image" />

By clicking the Add to Shopping Cart button, you certify to agree with our Terms of Service.

"Global Life Science Instruments and Reagents Market: Forecast up to 2025
[125 pages report] This market research report includes a detailed segmentation of the global life science instruments and reagents market – by technology (Spectrometry, Chromatography, Polymerase Chain Reaction (PCR), Biochips, Next-generation Sequencing (NGS), Flow Cytometry, Centrifugation, Electrophoresis, Microscopy, Liquid Handling Systems, Laboratory Freezers, and Others), and by Regions (North America, Europe, Asia Pacific, and Rest of the World).
Overview of the Global Life Science Instruments and Reagents Market Research:
Infoholic’s market research report predicts that the global life science instruments and reagents market will grow at a CAGR of 9.6% during the forecast period. The market has witnessed a steady growth in the past few years, and the development in technology with the introduction of novel products has augmented the acceptance of life science instruments in the market. The market is fueled by upsurge in chronic (including cancer), infectious, autoimmune disorders, and other types of diseases globally, growing interest & increasing awareness levels about the benefits of early-stage diagnosis, increasing spending on R&D by biotechnology & pharmaceutical firms, and growing adoption of emerging innovative applications, particularly in the life sciences industry.

Globally, the market continues to grow steadily with all technologies used widely by pharmaceutical, biotechnology, and diagnostic companies. The vendors are focusing on new product introduction and targeting toward end-user’s perspective. The industry consolidation rate is increasing as well because of mergers, acquisitions, and collaborations in the major markets of the US and Europe. In the mature markets, the leading vendors are focusing on new product launches and fast approvals as there is an increase in demand for developing new diagnostic procedures. This has led to an increase in R&D expenditure by the leading companies, mainly in the field of NGS, oligonucleotides-based reagents/assays, and other emerging areas within biological science. The industry concentration is medium to high with the majority of the revenue being generated by the key players operating in this field; few of them include Thermo Fisher Scientific, Inc., Illumina, Inc., Agilent Technologies, Inc., Merck KGaA, and Danaher Corporation.
According to Infoholic Research analysis, North America accounted for the largest share of the global life science instruments and reagents market in 2018 and will retain a high position during the forecast period. North America is followed by Europe with a share of more than 25% of the global market in 2018. The presence of a large number of biotechnology and pharmaceutical companies in North America makes it a dominant region in the global life science instruments and reagents market. Asia Pacific is projected to grow at a double-digit CAGR during the forecast period, owing to factors such as early adoption of novel technologies, increasing funding for healthcare research, growing healthcare expenditure, and favorable regulatory environment.
By Technology:
• Spectrometry
• Chromatography
• Polymerase Chain Reaction (PCR)
• Biochips
• Next-generation Sequencing (NGS)
• Flow Cytometry
• Centrifugation
• Electrophoresis
• Microscopy
• Liquid Handling Systems
• Laboratory Freezers
• Others
In 2018, the spectrometry segment accounted for the largest share and is expected to grow at a mid-single-digit CAGR during the forecast period. The NGS segment is expected to grow at a high CAGR during the forecast period 2019–2025 due to emerging diagnostic applications, continuous technological advancements, and more efficient & user-friendly techniques.
By Regions:
• North America
• Europe
• Asia Pacific
• Rest of the World
The market is dominated by the US (North America), followed by Europe and Asia Pacific. The US occupied a significant share mainly due to the presence of key vendors and the availability of advanced technologies.
Global Life Science Instruments and Reagents Market Research Competitive Analysis: The global life science instruments and reagents market has massive growth opportunities in both developed and developing regions. The innovation in instruments and reagents will increase the competition among the market players.
Many companies are focused on product approvals, funding, and development of new products related to life science instruments and reagents due to the increase in the demand for developing new diagnostic procedures. For instance, in November 2018, Thermo Fisher Scientific launched its FTIR spectrometer known as Nicolet iS20. The instrument features a new LightDrive Optical technology that enhances the analysis of complex samples to provide fast and accurate results. Exactly a year before, in November 2017, GNA Biosolutions GmbH had launched Pharos V8, the world’s first Laser PCR platform.
Another example is the launch of new INVENIO Fourier Transform Infrared (FT-IR) research spectrometer by Bruker in April 2018. This instrument is the successor to the renowned VERTEX 70 FT-IR for advanced R&D applications. In addition, other leading vendors are focusing on hugely investing in R&D activities to develop new products to obtain a high share in the market.
Key Vendors:
• Thermo Fisher Scientific, Inc.
• Illumina, Inc.
• Agilent Technologies, Inc.
• Merck KGaA
• Danaher Corporation
• Becton Dickinson and Company
• F. Hoffmann-La Roche (Roche)
• Bio-Rad Laboratories
• Promega Corporation
• GE Healthcare
• PerkinElmer, Inc.
• Bruker Corporation
• Waters Corporation
Key Competitive Facts:
• The market is highly competitive with all the players competing to gain the market share. Intense competition, rapid advancements in technology, frequent changes in government policies, and the prices are the key factors that confront the market.
• The requirement of high initial investment for the installation of certain life science instruments and maintenance cost in the market are also limiting the entry of new players.
Benefits – The report provides complete details about the usage and adoption rate of life science instruments and reagents. Thus, the key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives toward the medical devices segment in the upcoming years along with details of the pureplay companies entering the market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders in order to expand their business and capture the revenue in specific verticals, and to analyze before investing or expanding the business in this market.
Key Takeaways:
• Understanding the potential market opportunity with precise market size and forecast data.
• Detailed market analysis focusing on the growth of life science instruments and reagents industry.
• Factors influencing the growth of the life science instruments and reagents market.
• In-depth competitive analysis of dominant and pure-play vendors.
• Prediction analysis of the life science instruments and reagents industry in both developed and developing regions.
• Key insights related to major segments of the life science instruments and reagents market.
• Latest market trend analysis impacting the buying behavior of the consumers.
Key Stakeholders:

" "Table of Contents
1 INDUSTRY OUTLOOK 9
1.1 Industry Overview 9
1.2 Total Addressable Market 10
2 Report Outline 12
2.1 Report Scope 12
2.2 Report Summary 12
2.3 Research Methodology 13
2.4 Report Assumptions 14
3 Market Snapshot 15
3.1 Market Definition – Infoholic Research 15
3.2 Segmented Addressable Market (SAM) 15
3.3 Trends of the Life Science Instruments and Reagents Market 16
3.4 Related Markets 17
3.4.1 Polymerase Chain Reaction (PCR) 17
3.4.2 Next-Generation Sequencing (NGS) 18
3.4.3 Microarray 18
4 Market Outlook 20
4.1 Regulatory Scenario 20
4.1.1 North America 20
4.1.2 Europe 21
4.1.3 Asia 22
4.2 Market Segmentation 23
4.3 PEST Analysis 25
4.4 Porter 5 (Five) Forces 26
5 Market Characteristics 27
5.1 DRO – Global Life Science Instruments and Reagents Market Dynamics 27
5.1.1 Drivers 28
5.1.1.1 Increased technological advancements in analytical devices 28
5.1.1.2 Increase in spending on biotechnology and pharmaceutical R&D 28
5.1.2 Opportunities 29
5.1.2.1 High demand for the instrument from various industries 29
5.1.2.2 Growth opportunities in developing market 30
5.1.3 Restraints 30
5.1.3.1 High instrument cost 30
5.1.3.2 Lack of skilled professional 31
5.2 DRO – Impact Analysis 31
5.3 Key Stakeholders 32
6 Technology: Market Size and Analysis 34
6.1 Overview 34
6.2 Spectrometry 35
6.3 Chromatography 36
6.4 Polymerase Chain Reaction 37
6.5 Biochips 39
6.6 Next-generation Sequencing 40
6.7 Flow Cytometry 41
6.8 Centrifugation 42
6.9 Electrophoresis 44
6.10 Microscopy 45
6.11 Liquid Handling systems 46
6.12 Laboratory Freezers 47
6.13 Others 48
7 Regions: Market Size and Analysis 50
7.1 Overview 50
7.2 North America 51
7.3 Europe 53
7.4 Asia Pacific 55
7.5 Rest of the World 56
8 Competitive Landscape 58
8.1 Overview 58
9 Vendor Profiles 61
9.1 Thermo Fisher Scientific Inc. 61
9.1.1 Overview 61
9.1.2 Business Units 66
9.1.3 Geographic Presence 68
9.1.4 Business Focus 68
9.1.5 SWOT Analysis 69
9.1.6 Business Strategies 69
9.2 Illumina, Inc. 70
9.2.1 Overview 70
9.2.2 Business Units 76
9.2.3 Geographic Presence 77
9.2.4 Business Focus 78
9.2.5 SWOT Analysis 78
9.2.6 Business Strategies 79
9.3 Danaher Corporation 79
9.3.1 Overview 79
9.3.2 Business Units 83
9.3.3 Geographic Revenue 84
9.3.4 Business Focus 85
9.3.5 SWOT Analysis 86
9.3.6 Business Strategies 86
9.4 Agilent Technologies Inc 87
9.4.1 Overview 87
9.4.2 Business Units 91
9.4.3 Geographic Revenue 92
9.4.4 Business Focus 93
9.4.5 SWOT Analysis 94
9.4.6 Business Strategies 94
9.5 Merck KGaA 95
9.5.1 Overview 95
9.5.2 Business Units 98
9.5.3 Geographic Revenue 98
9.5.4 Business Focus 99
9.5.5 SWOT Analysis 100
9.5.6 Business Strategies 100
10 Companies to Watch For 102
10.1 Becton Dickinson and Company 102
10.1.1 Overview 102
10.2 Bio-Rad Laboratories 104
10.2.1 Overview 104
10.3 F. Hoffmann-La Roche 107
10.3.1 Overview 107
10.4 Shimadzu Corp. 109
10.4.1 Overview 109
10.5 GE Healthcare 111
10.5.1 Overview 111
10.6 Promega Corporation 114
10.6.1 Overview 114
10.7 Bruker Corporation 115
10.7.1 Overview 115
10.8 PerkinElmer, Inc. 119
10.8.1 Overview 119
10.9 Waters Corporation 122
10.9.1 Overview 122
11 Annexure 126
11.1 Abbreviations 126

" "TABLE 1 GLOBAL LIFE SCIENCE INSTRUMENTS AND REAGENTS MARKET REVENUE BY REGIONS, 2018–2025 ($MILLION) 51
TABLE 2 OTHER PROMINENT VENDORS OF LIFE SCIENCE INSTRUMENTS AND REAGENTS MARKET 59
TABLE 3 THERMO FISHER SCIENTIFIC INC.: OFFERINGS 61
TABLE 4 THERMO FISHER SCIENTIFIC: RECENT DEVELOPMENTS 63
TABLE 5 ILLUMINA, INC.: PRODUCT OFFERINGS 70
TABLE 6 ILLUMINA, INC.: RECENT DEVELOPMENTS 71
TABLE 7 DANAHER CORPORATION: PRODUCT OFFERINGS 80
TABLE 8 DANAHER CORPORATION: RECENT DEVELOPMENTS 81
TABLE 9 AGILENT TECHNOLOGIES INC: OFFERINGS 88
TABLE 10 AGILENT TECHNOLOGIES INC: RECENT DEVELOPMENTS 88
TABLE 11 MERCK KGAA: PRODUCT OFFERINGS 95
TABLE 12 MERCK KGAA: RECENT DEVELOPMENTS 96
TABLE 13 BECTON DICKINSON AND COMPANY: SNAPSHOT 102
TABLE 14 BECTON DICKINSON AND COMPANY: RECENT DEVELOPMENTS 103
TABLE 15 BIO-RAD LABORATORIES: SNAPSHOT 105
TABLE 16 BIO-RAD LABORATORIES: RECENT DEVELOPMENTS 105
TABLE 17 F. HOFFMANN-LA ROCHE: SNAPSHOT 107
TABLE 18 F. HOFFMANN-LA ROCHE: RECENT DEVELOPMENTS 107
TABLE 19 SHIMADZU CORP.: SNAPSHOT 110
TABLE 20 SHIMADZU CORP.: RECENT DEVELOPMENTS 110
TABLE 21 GE HEALTHCARE: SNAPSHOT 111
TABLE 22 GE HEALTHCARE: RECENT DEVELOPMENTS 112
TABLE 23 PROMEGA CORPORATION: SNAPSHOT 114
TABLE 24 PROMEGA CORPORATION: RECENT DEVELOPMENTS 115
TABLE 25 BRUKER CORPORATION: SNAPSHOT 116
TABLE 26 BRUKER CORPORATION: RECENT DEVELOPMENTS 117
TABLE 27 PERKINELMER, INC.: SNAPSHOT 120
TABLE 28 PERKINELMER, INC.: RECENT DEVELOPMENTS 121
TABLE 29 WATERS CORPORATION: SNAPSHOT 122
TABLE 30 WATERS CORPORATION: RECENT DEVELOPMENTS 123


" "Charts
CHART 1 RESEARCH METHODOLOGY OF GLOBAL LIFE SCIENCE INSTRUMENTS AND REAGENTS MARKET 12
CHART 2 GLOBAL LIFE SCIENCE INSTRUMENTS AND REAGENTS MARKET REVENUE, 2018–2025 ($MILLION) 15
CHART 3 SEGMENTATION OF GLOBAL LIFE SCIENCE INSTRUMENTS AND REAGENTS MARKET 21
CHART 4 PEST ANALYSIS OF GLOBAL LIFE SCIENCE INSTRUMENTS AND REAGENTS MARKET 22
CHART 5 PORTER 5 FORCES ON GLOBAL LIFE SCIENCE INSTRUMENTS AND REAGENTS MARKET 23
CHART 6 MARKET DYNAMICS – DRO ANALYSIS 24
CHART 7 DRO – IMPACT ANALYSIS OF GLOBAL LIFE SCIENCE INSTRUMENTS AND REAGENTS MARKET 28
CHART 8 KEY STAKEHOLDERS 29
CHART 9 GLOBAL LIFE SCIECE INSTRUMENTS AND REAGENTS MARKET BY TECHNOLOGY SEGMENTATION,
2018 (%) 31
CHART 10 GLOBAL LIFE SCIECE INSTRUMENTS AND REAGENTS MARKET BY TECHNOLOGY SEGMENTATION,
2025 (%) 31
CHART 11 GLOBAL SPECTROMETRY MARKET FORECAST, 2018–2025 ($MILLION) 33
CHART 12 GLOBAL CHROMATOGRAPHY MARKET FORECAST, 2018–2025 ($MILLION) 34
CHART 13 GLOBAL POLYMERASE CHAIN REACTION MARKET FORECAST, 2018–2025 ($MILLION) 35
CHART 14 GLOBAL BIOCHIPS MARKET FORECAST, 2018–2025 ($MILLION) 36
CHART 15 GLOBAL NEXT-GENERATION SEQUENCING MARKET FORECAST, 2018–2025 ($MILLION) 37
CHART 16 GLOBAL FLOW CYTOMETRY MARKET FORECAST, 2018–2025 ($MILLION) 38
CHART 17 GLOBAL CENTRIFUGATION MARKET FORECAST, 2018–2025 ($MILLION) 39
CHART 18 GLOBAL ELECTROPHORESIS MARKET FORECAST, 2018–2025 ($MILLION) 40
CHART 19 GLOBAL MICROSCOPY MARKET FORECAST, 2018–2025 ($MILLION) 41
CHART 20 GLOBAL LIQUID HANDLING SYSTEMS MARKET FORECAST, 2018–2025 ($MILLION) 42
CHART 21 GLOBAL LABORATORY FREEZERS MARKET FORECAST, 2018–2025 ($MILLION) 43
CHART 22 GLOBAL OTHERS MARKET FORECAST, 2018–2025 ($MILLION) 44
CHART 23 GLOBAL LIFE SCIENCE INSTRUMENTS AND REAGENTS MARKET BY GEOGRAPHICAL
SEGMENTATION, 2018 (%) 45
CHART 24 GLOBAL LIFE SCIENCE INSTRUMEMTS AND REAGENTS MARKET BY GEOGRAPHICAL
SEGMENTATION, 2025 (%) 46
CHART 25 LIFE SCIENCE INSTRUMENTS AND REAGENTS MARKET REVENUE IN NORTH AMERICA,
2018–2025 ($MILLION) 47
CHART 26 LIFE SCIENCE INSTRUMENTS AND REAGENTS MARKET REVENUE IN EUROPE, 2018–2025
($MILLION) 49
CHART 27 LIFE SCIENCE INSTRUMENTS AND REAGENTS MARKET REVENUE IN ASIA PACIFIC, 2018–2025 ($MILLION) 51
CHART 28 LIFE SCIENCE INSTRUMENTS AND REAGENTS MARKET REVENUE IN REST OF THE WORLD,
2018–2025 ($MILLION) 52
CHART 29 THERMO FISHER SCIENTIFIC: OVERVIEW SNAPSHOT 61
CHART 30 THERMO FISHER SCIENTIFIC: BUSINESS UNITS 62
CHART 31 THERMO FISHER SCIENTIFIC INC.: GEOGRAPHIC PRESENCE 63
CHART 32 THERMO FISHER SCIENTIFIC: SWOT ANALYSIS 64
CHART 33 ILLUMINA, INC.: OVERVIEW SNAPSHOT 70
CHART 34 ILLUMINA, INC.: BUSINESS UNITS 71
CHART 35 ILLUMINA, INC.: GEOGRAPHIC PRESENCE 72
CHART 36 ILLUMINA, INC.: SWOT ANALYSIS 73
CHART 37 DANAHER CORPORATION: OVERVIEW SNAPSHOT 78
CHART 38 DANAHER CORPORATION: BUSINESS UNITS 78
CHART 39 DANAHER CORPORATION: GEOGRAPHIC REVENUE 79
CHART 40 DANAHER CORPORATION: SWOT ANALYSIS 81
CHART 41 AGILENT TECHNOLOGIES INC.: OVERVIEW SNAPSHOT 85
CHART 42 AGILENT TECHNOLOGIES INC.: BUSINESS UNITS 86
CHART 43 AGILENT TECHNOLOGIES: GEOGRAPHICAL REVENUE 87
CHART 44 AGILENT TECHNOLOGIES INC.: SWOT ANALYSIS 89
CHART 45 MERCK KGAA: OVERVIEW SNAPSHOT 92
CHART 46 MERCK KGAA: BUSINESS UNITS 93
CHART 47 MERCK KGAA: GEOGRAPHICAL REVENUE 93
CHART 48 MERCK KGAA: SWOT ANALYSIS 95

 

"

Reviews

There are yet no reviews for this product.